Better Therapeutics, Inc.

Better Therapeutics, Inc. (Nasdaq: BTTX) is a digital therapeutics company that entered the public markets in 2021 through its business combination with Mountain Crest Acquisition Corp. II, a blank-check vehicle sponsored by Mountain Crest Capital LLC. The company focused on developing prescription digital therapeutics for cardiometabolic diseases, applying software-delivered cognitive behavioral therapy as an adjunct to standard clinical care. On May 30, 2024, Better Therapeutics filed a Form 15-12G with the SEC, certifying the termination of its registration under Section 12(g) of the Securities Exchange Act of 1934 and ending its public reporting obligations, effectively taking the company dark. Visitors seeking full filing history, transaction data, and status tracking for BTTX and other SPAC deals are encouraged to sign up at SpacDesk.